The European Medicines Agency ' s EU conditional marketing authorisations for COVID-19 vaccines, The Lancet

Commentary notes approvals of first COVID-19 vaccines in EU are a key milestone in response to COVID-19, which not only offer hope to control the pandemic but also provide proof of concept for a new approach to vaccine development in response to future emerging health threats.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news